Irene Cortese (National Institute of Neurological Disorders and Stroke) discusses the difficulties of designing clinical trials in progressive multifocal leukoencephalopathy and talks about a pilot study of virus-specific T cells for treatment of this population, published in the August issue of The Lancet Neurology.

Read the full article:
https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(21)00174-5/fulltext